U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 07:24:10 GMT 2025
Edited
by admin
on Wed Apr 02 07:24:10 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
DCI3L5GHC9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
mipasetamab [INN]
Preferred Name English
MIPASETAMAB
INN   USAN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS AXL (AXL RECEPTOR TYROSINE KINASE, TYROSINE-PROTEIN KINASE RECEPTOR UFO)), HUMANIZED MONOCLONAL ANTIBODY (MIPASETAMAB)
Common Name English
1H12-HAKB
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE AXL) (HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .KAPPA.-CHAIN, DIMER, 302,302'-BIS(N-(O-2-(ACETYLAMINO)-6-AZIDO-2,6-DIDEOXY-.BETA.-D-GALAC
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE; EC=2.7.10.1)); HUMANIZED MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-451) (VH HUMANIZED (HOMO SAPIENS IGHV3-30*03 (93%)-(IGHD)-IGHJ4*01 (92%)) (8.8
Common Name English
MIPASETAMAB [USAN]
Common Name English
1H12-GALNACN3
Code English
Code System Code Type Description
INN
11483
Created by admin on Wed Apr 02 07:24:10 GMT 2025 , Edited by admin on Wed Apr 02 07:24:10 GMT 2025
PRIMARY
FDA UNII
DCI3L5GHC9
Created by admin on Wed Apr 02 07:24:10 GMT 2025 , Edited by admin on Wed Apr 02 07:24:10 GMT 2025
PRIMARY
CAS
2361055-48-1
Created by admin on Wed Apr 02 07:24:10 GMT 2025 , Edited by admin on Wed Apr 02 07:24:10 GMT 2025
PRIMARY
USAN
JK-249
Created by admin on Wed Apr 02 07:24:10 GMT 2025 , Edited by admin on Wed Apr 02 07:24:10 GMT 2025
PRIMARY
SMS_ID
300000032572
Created by admin on Wed Apr 02 07:24:10 GMT 2025 , Edited by admin on Wed Apr 02 07:24:10 GMT 2025
PRIMARY
NCI_THESAURUS
C175822
Created by admin on Wed Apr 02 07:24:10 GMT 2025 , Edited by admin on Wed Apr 02 07:24:10 GMT 2025
PRIMARY
From To
2_225 4_215
1_225 3_215
1_22 1_96
2_22 2_96
1_149 1_205
2_149 2_205
1_231 2_231
1_234 2_234
1_266 1_326
2_266 2_326
1_372 1_430
2_372 2_430
3_23 3_89
4_23 4_89
3_135 3_195
4_135 4_195
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_302
N 2_302
Related Record Type Details
CONJUGATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Immunomodulator, antineoplastic

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
AMINO_ACID_SUBSTITUTION [1_302] [2_302] SITE_SPECIFIC Amount: UNSPECIFIED SUBSTANCE
eed341e7
(not in database)
AMINO_ACID_SUBSTITUTION [1_302] SITE_SPECIFIC Amount: UNSPECIFIED SUBSTANCE
d2a1f71b
(not in database)
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL